Preterm Birth and 17OHP - Why the FDA Should Not Withdraw Approval.

Michael F Greene Mark A Klebanoff David Harrington

N Engl J Med

From the Department of Obstetrics and Gynecology, Massachusetts General Hospital (M.F.G.), the Harvard T.H. Chan School of Public Health (D.H.), and the Dana-Farber Cancer Institute (D.H.) - all in Boston; and Nationwide Children's Hospital, Ohio State University College of Medicine, and Ohio State University College of Public Health - all in Columbus (M.A.K.).

Published: December 2020

Download full-text PDF	Source
http://dx.doi.org/10.1056/NEJMp2031727	DOI Listing

Publication Analysis

Top Keywords

preterm birth

birth 17ohp

17ohp fda

fda withdraw

withdraw approval

preterm

17ohp

fda

withdraw

approval

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!